Global Analgesic and Anti-inflammatory API Industry Research & Trends Analysis Report
According to Market IntelliX Research, the global market for Analgesic and Anti-inflammatory API should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
China Analgesic and Anti-inflammatory API market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
The United States Analgesic and Anti-inflammatory API market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
In terms of type, Ibuprofen segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Adults has a share approximately % in 2023 and will grow at a CAGR % during 2024 and 2030.
The global key manufacturers of Analgesic and Anti-inflammatory API include IOL, Mallinckrodt Pharmaceuticals, Anqiu Lu'an Pharmaceutical, Novacyl, BASF, BBCA Group, Hubei Biocause Group, Xinhua Pharm and Granules India Limited, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.
Analgesics, also called painkillers, are medications that relieve different types of pain — from headaches to injuries to arthritis. Anti-inflammatory analgesics reduce inflammation, and opioid analgesics change the way the brain perceives pain.
This report aims to provide a comprehensive study of the global market for Analgesic and Anti-inflammatory API. Report Highlights:
(1) Global Analgesic and Anti-inflammatory API market size (sales volume & revenue),history data from 2019-2024 and forecast data from 2024 to 2030.
(2) Global Analgesic and Anti-inflammatory API market competitive situation, sales, revenue, price and market share, from 2019 to 2024.
(3) China Analgesic and Anti-inflammatory API market competitive situation, sales, revenue, price and market share, from 2019 to 2024.
(4) Global Analgesic and Anti-inflammatory API segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Analgesic and Anti-inflammatory API segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Analgesic and Anti-inflammatory API, capacity, production and trends.
(7) Analgesic and Anti-inflammatory API industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Ibuprofen
Paracetamol
Aspirin
Naproxen
Diclofenac
Oxaprozin
Dexibuprofen
Others
Market segment by application, can be divided into
Adults
Children
Market segment by players, this report covers
IOL
Mallinckrodt Pharmaceuticals
Anqiu Lu'an Pharmaceutical
Novacyl
BASF
BBCA Group
Hubei Biocause Group
Xinhua Pharm
Granules India Limited
Hebei Jiheng Pharmaceutical
Zhejiang Kangle Pharmaceutical
Hunan Zhongnan Pharmaceutical
Hebei Jingye Medical Technology
1 Market Overview
1.1 Analgesic and Anti-inflammatory API Definition
1.2 Global Analgesic and Anti-inflammatory API Market Size and Forecast
1.2.1 By Revenue, Global Analgesic and Anti-inflammatory API Market Size, 2019-2030
1.2.2 By Sales Volume, Global Analgesic and Anti-inflammatory API Market Size, 2019-2030
1.2.3 Global Analgesic and Anti-inflammatory API Price Trend, 2019-2030
1.3 China Analgesic and Anti-inflammatory API Market Size and Forecast
1.3.1 By Revenue, China Analgesic and Anti-inflammatory API Market Size, 2019-2030
1.3.2 By Sales Volume, China Analgesic and Anti-inflammatory API Market Size, 2019-2030
1.3.3 China Analgesic and Anti-inflammatory API Price Trend, 2019-2030
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Analgesic and Anti-inflammatory API Share in Global Market, 2019-2030
1.4.2 By Sales Volume, China Analgesic and Anti-inflammatory API Share in Global Market, 2019-2030
1.4.3 Analgesic and Anti-inflammatory API Market Size: China VS Global, 2019-2030
1.5 Analgesic and Anti-inflammatory API Market Dynamics
1.5.1 Analgesic and Anti-inflammatory API Market Drivers
1.5.2 Analgesic and Anti-inflammatory API Market Restraints
1.5.3 Analgesic and Anti-inflammatory API Industry Trends
1.5.4 Analgesic and Anti-inflammatory API Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Analgesic and Anti-inflammatory API Revenue by Company, 2019-2024
2.2 Global Analgesic and Anti-inflammatory API Sales Volume by Company, 2019-2024
2.3 Global Analgesic and Anti-inflammatory API Price by Company, 2019-2024
2.4 Global Analgesic and Anti-inflammatory API Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Analgesic and Anti-inflammatory API Concentration Ratio
2.6 Global Analgesic and Anti-inflammatory API Mergers & Acquisitions, Expansion Plans
2.7 Global Analgesic and Anti-inflammatory API Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Analgesic and Anti-inflammatory API Revenue by Company, 2019-2024
3.2 China Analgesic and Anti-inflammatory API Sales Volume by Company, 2019-2024
3.3 China Analgesic and Anti-inflammatory API Analgesic and Anti-inflammatory API Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Analgesic and Anti-inflammatory API Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)
3.5 Chinese Local Players, Analgesic and Anti-inflammatory API Domestic VS Export
3.6 China Market, Analgesic and Anti-inflammatory API Import & Export
3.6.1 China Market, Analgesic and Anti-inflammatory API Import & Export, 2019-2030
3.6.2 China Analgesic and Anti-inflammatory API Import & Export Trends
3.6.3 Main Sources of China Analgesic and Anti-inflammatory API Import
3.6.4 Export Destination of China Analgesic and Anti-inflammatory API
4 Analgesic and Anti-inflammatory API Production by Region
4.1 Global Analgesic and Anti-inflammatory API Capacity, Production and Capacity Utilization, 2019-2030
4.2 Global Geographic Distribution of Analgesic and Anti-inflammatory API Manufacturers
4.3 Global Major Manufacturers, Analgesic and Anti-inflammatory API Capacity Expansion and Future Plans
4.4 Global Analgesic and Anti-inflammatory API Capacity by Region
4.5 Global Analgesic and Anti-inflammatory API Production by Region
4.5.1 Global Analgesic and Anti-inflammatory API Production & Forecast by Region, 2019 VS 2024 VS 2030
4.5.2 Global Analgesic and Anti-inflammatory API Production by Region, 2019-2024
4.5.3 Global Analgesic and Anti-inflammatory API Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Analgesic and Anti-inflammatory API Industry Chain
5.2 Analgesic and Anti-inflammatory API Upstream Analysis
5.2.1 Analgesic and Anti-inflammatory API Core Raw Materials
5.2.2 Main Manufacturers of Analgesic and Anti-inflammatory API Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Analgesic and Anti-inflammatory API Production Mode
5.6 Analgesic and Anti-inflammatory API Procurement Model
5.7 Analgesic and Anti-inflammatory API Industry Sales Model and Sales Channels
5.7.1 Analgesic and Anti-inflammatory API Sales Model
5.7.2 Analgesic and Anti-inflammatory API Typical Distributors
6 Sights by Type
6.1 Analgesic and Anti-inflammatory API Classification
6.1.1 Ibuprofen
6.1.2 Paracetamol
6.1.3 Aspirin
6.1.4 Naproxen
6.1.5 Diclofenac
6.1.6 Oxaprozin
6.1.7 Dexibuprofen
6.1.8 Others
6.2 By Type, Global Analgesic and Anti-inflammatory API Market Size & CAGR, 2019 VS 2024 VS 2030
6.3 By Type, Global Analgesic and Anti-inflammatory API Revenue, 2019-2030
6.4 By Type, Global Analgesic and Anti-inflammatory API Sales Volume, 2019-2030
6.5 By Type, Global Analgesic and Anti-inflammatory API Price, 2019-2030
7 Sights by Application
7.1 Analgesic and Anti-inflammatory API Segment by Application
7.1.1 Adults
7.1.2 Children
7.2 By Application, Global Analgesic and Anti-inflammatory API Market Size & CAGR, 2019 VS 2024 VS 2030
7.3 By Application, Global Analgesic and Anti-inflammatory API Revenue, 2019-2030
7.4 By Application, Global Analgesic and Anti-inflammatory API Sales Volume, 2019-2030
7.5 By Application, Global Analgesic and Anti-inflammatory API Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Analgesic and Anti-inflammatory API Market Size, 2019 VS 2024 VS 2030
8.2 By Region, Global Analgesic and Anti-inflammatory API Revenue, 2019-2030
8.3 By Region, Global Analgesic and Anti-inflammatory API Sales Volume, 2019-2030
8.4 North America
8.4.1 North America Analgesic and Anti-inflammatory API Market Size & Forecasts, 2019-2030
8.4.2 By Country, North America Analgesic and Anti-inflammatory API Market Size Market Share
8.5 Europe
8.5.1 Europe Analgesic and Anti-inflammatory API Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Analgesic and Anti-inflammatory API Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Analgesic and Anti-inflammatory API Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Analgesic and Anti-inflammatory API Market Size Market Share
8.7 South America
8.7.1 South America Analgesic and Anti-inflammatory API Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Analgesic and Anti-inflammatory API Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Analgesic and Anti-inflammatory API Market Size & CAGR，2019 VS 2024 VS 2030
9.2 By Country, Global Analgesic and Anti-inflammatory API Revenue, 2019-2030
9.3 By Country, Global Analgesic and Anti-inflammatory API Sales Volume, 2019-2030
9.4 U.S.
9.4.1 U.S. Analgesic and Anti-inflammatory API Market Size, 2019-2030
9.4.2 By Company, U.S. Analgesic and Anti-inflammatory API Sales Volume Market Share, 2023
9.4.3 By Type, U.S. Analgesic and Anti-inflammatory API Market Size, Share, 2023 VS 2030
9.4.4 By Application, U.S. Analgesic and Anti-inflammatory API Market Size, Share, 2023 VS 2030
9.5 Europe
9.5.1 Europe Analgesic and Anti-inflammatory API Market Size, 2019-2030
9.5.2 By Company, Europe Analgesic and Anti-inflammatory API Sales Volume Market Share, 2023
9.5.3 By Type, Europe Analgesic and Anti-inflammatory API Market Size, Share, 2023 VS 2030
9.5.4 By Application, Europe Analgesic and Anti-inflammatory API Market Size, Share, 2023 VS 2030
9.6 China
9.6.1 China Analgesic and Anti-inflammatory API Market Size, 2019-2030
9.6.2 By Company, China Analgesic and Anti-inflammatory API Sales Volume Market Share, 2023
9.6.3 By Type, China Analgesic and Anti-inflammatory API Market Size, Share, 2023 VS 2030
9.6.4 By Application, China Analgesic and Anti-inflammatory API Market Size, Share, 2023 VS 2030
9.7 Japan
9.7.1 Japan Analgesic and Anti-inflammatory API Market Size, 2019-2030
9.7.2 By Company, Japan Analgesic and Anti-inflammatory API Sales Volume Market Share, 2023
9.7.3 By Type, Japan Analgesic and Anti-inflammatory API Market Size, Share, 2023 VS 2030
9.7.4 By Application, Japan Analgesic and Anti-inflammatory API Market Size, Share, 2023 VS 2030
9.8 South Korea
9.8.1 South Korea Analgesic and Anti-inflammatory API Market Size, 2019-2030
9.8.2 By Company, South Korea Analgesic and Anti-inflammatory API Sales Volume Market Share, 2023
9.8.3 By Type, South Korea Analgesic and Anti-inflammatory API Market Size, Share, 2023 VS 2030
9.8.4 By Application, South Korea Analgesic and Anti-inflammatory API Market Size, Share, 2023 VS 2030
9.9 Southeast Asia
9.9.1 Southeast Asia Analgesic and Anti-inflammatory API Market Size, 2019-2030
9.9.2 By Company, Southeast Asia Analgesic and Anti-inflammatory API Sales Volume Market Share, 2023
9.9.3 By Type, Southeast Asia Analgesic and Anti-inflammatory API Market Size, Share, 2023 VS 2030
9.9.4 By Application, Southeast Asia Analgesic and Anti-inflammatory API Market Size, Share, 2023 VS 2030
9.10 India
9.10.1 India Analgesic and Anti-inflammatory API Market Size, 2019-2030
9.10.2 By Company, India Analgesic and Anti-inflammatory API Sales Volume Market Share, 2023
9.10.3 By Type, India Analgesic and Anti-inflammatory API Market Size, Share, 2023 VS 2030
9.10.4 By Application, India Analgesic and Anti-inflammatory API Market Size, Share, 2023 VS 2030
9.11 Middle East & Asia
9.11.1 Middle East & Asia Analgesic and Anti-inflammatory API Market Size, 2019-2030
9.11.2 By Company, Middle East & Asia Analgesic and Anti-inflammatory API Sales Volume Market Share, 2023
9.11.3 By Type, Middle East & Asia Analgesic and Anti-inflammatory API Market Size, Share, 2023 VS 2030
9.11.4 By Application, Middle East & Asia Analgesic and Anti-inflammatory API Market Size, Share, 2023 VS 2030
10 Manufacturers Profile
10.1 IOL
10.1.1 IOL Company Information, Head Office, Market Area and Industry Position
10.1.2 IOL Analgesic and Anti-inflammatory API Models, Specifications and Application
10.1.3 IOL Analgesic and Anti-inflammatory API Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.1.4 IOL Company Profile and Main Business
10.1.5 IOL Recent Developments
10.2 Mallinckrodt Pharmaceuticals
10.2.1 Mallinckrodt Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.2.2 Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Models, Specifications and Application
10.2.3 Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.2.4 Mallinckrodt Pharmaceuticals Company Profile and Main Business
10.2.5 Mallinckrodt Pharmaceuticals Recent Developments
10.3 Anqiu Lu'an Pharmaceutical
10.3.1 Anqiu Lu'an Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.3.2 Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Models, Specifications and Application
10.3.3 Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Anqiu Lu'an Pharmaceutical Company Profile and Main Business
10.3.5 Anqiu Lu'an Pharmaceutical Recent Developments
10.4 Novacyl
10.4.1 Novacyl Company Information, Head Office, Market Area and Industry Position
10.4.2 Novacyl Analgesic and Anti-inflammatory API Models, Specifications and Application
10.4.3 Novacyl Analgesic and Anti-inflammatory API Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Novacyl Company Profile and Main Business
10.4.5 Novacyl Recent Developments
10.5 BASF
10.5.1 BASF Company Information, Head Office, Market Area and Industry Position
10.5.2 BASF Analgesic and Anti-inflammatory API Models, Specifications and Application
10.5.3 BASF Analgesic and Anti-inflammatory API Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.5.4 BASF Company Profile and Main Business
10.5.5 BASF Recent Developments
10.6 BBCA Group
10.6.1 BBCA Group Company Information, Head Office, Market Area and Industry Position
10.6.2 BBCA Group Analgesic and Anti-inflammatory API Models, Specifications and Application
10.6.3 BBCA Group Analgesic and Anti-inflammatory API Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.6.4 BBCA Group Company Profile and Main Business
10.6.5 BBCA Group Recent Developments
10.7 Hubei Biocause Group
10.7.1 Hubei Biocause Group Company Information, Head Office, Market Area and Industry Position
10.7.2 Hubei Biocause Group Analgesic and Anti-inflammatory API Models, Specifications and Application
10.7.3 Hubei Biocause Group Analgesic and Anti-inflammatory API Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.7.4 Hubei Biocause Group Company Profile and Main Business
10.7.5 Hubei Biocause Group Recent Developments
10.8 Xinhua Pharm
10.8.1 Xinhua Pharm Company Information, Head Office, Market Area and Industry Position
10.8.2 Xinhua Pharm Analgesic and Anti-inflammatory API Models, Specifications and Application
10.8.3 Xinhua Pharm Analgesic and Anti-inflammatory API Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.8.4 Xinhua Pharm Company Profile and Main Business
10.8.5 Xinhua Pharm Recent Developments
10.9 Granules India Limited
10.9.1 Granules India Limited Company Information, Head Office, Market Area and Industry Position
10.9.2 Granules India Limited Analgesic and Anti-inflammatory API Models, Specifications and Application
10.9.3 Granules India Limited Analgesic and Anti-inflammatory API Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.9.4 Granules India Limited Company Profile and Main Business
10.9.5 Granules India Limited Recent Developments
10.10 Hebei Jiheng Pharmaceutical
10.10.1 Hebei Jiheng Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.10.2 Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Models, Specifications and Application
10.10.3 Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.10.4 Hebei Jiheng Pharmaceutical Company Profile and Main Business
10.10.5 Hebei Jiheng Pharmaceutical Recent Developments
10.11 Zhejiang Kangle Pharmaceutical
10.11.1 Zhejiang Kangle Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.11.2 Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Models, Specifications and Application
10.11.3 Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.11.4 Zhejiang Kangle Pharmaceutical Company Profile and Main Business
10.11.5 Zhejiang Kangle Pharmaceutical Recent Developments
10.12 Hunan Zhongnan Pharmaceutical
10.12.1 Hunan Zhongnan Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.12.2 Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Models, Specifications and Application
10.12.3 Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.12.4 Hunan Zhongnan Pharmaceutical Company Profile and Main Business
10.12.5 Hunan Zhongnan Pharmaceutical Recent Developments
10.13 Hebei Jingye Medical Technology
10.13.1 Hebei Jingye Medical Technology Company Information, Head Office, Market Area and Industry Position
10.13.2 Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Models, Specifications and Application
10.13.3 Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.13.4 Hebei Jingye Medical Technology Company Profile and Main Business
10.13.5 Hebei Jingye Medical Technology Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Analgesic and Anti-inflammatory API Market Size & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Analgesic and Anti-inflammatory API Market Restraints
Table 3. Analgesic and Anti-inflammatory API Market Trends
Table 4. Analgesic and Anti-inflammatory API Industry Policy
Table 5. Global Analgesic and Anti-inflammatory API Revenue by Company, 2019-2024, US$ million
Table 6. Global Analgesic and Anti-inflammatory API Revenue Market Share by Company, 2019-2024
Table 7. Global Analgesic and Anti-inflammatory API Sales Volume by Company, 2019-2024, (Tons)
Table 8. Global Analgesic and Anti-inflammatory API Sales Volume Market Share by Company, 2019-2024
Table 9. Global Analgesic and Anti-inflammatory API Price by Company, 2019-2024, (US$/Ton)
Table 10. Global Analgesic and Anti-inflammatory API Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Analgesic and Anti-inflammatory API Mergers & Acquisitions, Expansion Plans
Table 12. Global Analgesic and Anti-inflammatory API Manufacturers Product Type
Table 13. China Analgesic and Anti-inflammatory API Revenue by Company, 2019-2024, US$ million
Table 14. China Analgesic and Anti-inflammatory API Revenue Market Share by Company, 2019-2024
Table 15. China Analgesic and Anti-inflammatory API Sales Volume by Company, 2019-2024, (Tons)
Table 16. China Analgesic and Anti-inflammatory API Sales Volume Market Share by Company, 2019-2024
Table 17. China Market, Analgesic and Anti-inflammatory API Production, Sales, Import and Export, 2019-2030, (Tons)
Table 18. China Analgesic and Anti-inflammatory API Import & Export Trends
Table 19. Main Sources of China Analgesic and Anti-inflammatory API Import
Table 20. Export Destination of China Analgesic and Anti-inflammatory API
Table 21. Global Headquarters and Manufacturing Base of Analgesic and Anti-inflammatory API Manufacturers
Table 22. Global Major Manufacturers, Analgesic and Anti-inflammatory API Capacity Expansion and Future Plans
Table 23. Global Analgesic and Anti-inflammatory API Production & Forecast by Region, 2019 VS 2024 VS 2030, (Tons)
Table 24. Global Analgesic and Anti-inflammatory API Production by Region, 2019-2024, (Tons)
Table 25. Global Analgesic and Anti-inflammatory API Production Forecast by Region, 2024-2030, (Tons)
Table 26. Global Key Players of Analgesic and Anti-inflammatory API Upstream (Raw Materials)
Table 27. Global Analgesic and Anti-inflammatory API Typical Customers
Table 28. Analgesic and Anti-inflammatory API Typical Distributors
Table 29. By Type, Global Analgesic and Anti-inflammatory API Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 30. By Application, Global Analgesic and Anti-inflammatory API Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 31. By Region, Global Analgesic and Anti-inflammatory API Market Size, 2019 VS 2024 VS 2030, US$ Million
Table 32. By Region, Global Analgesic and Anti-inflammatory API Revenue, 2019-2030, US$ Million
Table 33. By Region, Global Analgesic and Anti-inflammatory API Sales Volume, 2019-2030, (Tons)
Table 34. By Country, Global Analgesic and Anti-inflammatory API Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million
Table 35. By Country, Global Analgesic and Anti-inflammatory API Revenue, 2019-2030, US$ Million
Table 36. By Country, Global Analgesic and Anti-inflammatory API Revenue Market Share, 2019-2030
Table 37. By Country, Global Analgesic and Anti-inflammatory API Sales Volume, 2019-2030, (Tons)
Table 38. By Country, Global Analgesic and Anti-inflammatory API Sales Volume Market Share, 2019-2030
Table 39. IOL Company Information, Head Office, Market Area and Industry Position
Table 40. IOL Analgesic and Anti-inflammatory API Models, Specifications and Application
Table 41. IOL Analgesic and Anti-inflammatory API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 42. IOL Company Profile and Main Business
Table 43. IOL Recent Developments
Table 44. Mallinckrodt Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 45. Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Models, Specifications and Application
Table 46. Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 47. Mallinckrodt Pharmaceuticals Company Profile and Main Business
Table 48. Mallinckrodt Pharmaceuticals Recent Developments
Table 49. Anqiu Lu'an Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 50. Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Models, Specifications and Application
Table 51. Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 52. Anqiu Lu'an Pharmaceutical Company Profile and Main Business
Table 53. Anqiu Lu'an Pharmaceutical Recent Developments
Table 54. Novacyl Company Information, Head Office, Market Area and Industry Position
Table 55. Novacyl Analgesic and Anti-inflammatory API Models, Specifications and Application
Table 56. Novacyl Analgesic and Anti-inflammatory API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 57. Novacyl Company Profile and Main Business
Table 58. Novacyl Recent Developments
Table 59. BASF Company Information, Head Office, Market Area and Industry Position
Table 60. BASF Analgesic and Anti-inflammatory API Models, Specifications and Application
Table 61. BASF Analgesic and Anti-inflammatory API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 62. BASF Company Profile and Main Business
Table 63. BASF Recent Developments
Table 64. BBCA Group Company Information, Head Office, Market Area and Industry Position
Table 65. BBCA Group Analgesic and Anti-inflammatory API Models, Specifications and Application
Table 66. BBCA Group Analgesic and Anti-inflammatory API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 67. BBCA Group Company Profile and Main Business
Table 68. BBCA Group Recent Developments
Table 69. Hubei Biocause Group Company Information, Head Office, Market Area and Industry Position
Table 70. Hubei Biocause Group Analgesic and Anti-inflammatory API Models, Specifications and Application
Table 71. Hubei Biocause Group Analgesic and Anti-inflammatory API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 72. Hubei Biocause Group Company Profile and Main Business
Table 73. Hubei Biocause Group Recent Developments
Table 74. Xinhua Pharm Company Information, Head Office, Market Area and Industry Position
Table 75. Xinhua Pharm Analgesic and Anti-inflammatory API Models, Specifications and Application
Table 76. Xinhua Pharm Analgesic and Anti-inflammatory API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 77. Xinhua Pharm Company Profile and Main Business
Table 78. Xinhua Pharm Recent Developments
Table 79. Granules India Limited Company Information, Head Office, Market Area and Industry Position
Table 80. Granules India Limited Analgesic and Anti-inflammatory API Models, Specifications and Application
Table 81. Granules India Limited Analgesic and Anti-inflammatory API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 82. Granules India Limited Company Profile and Main Business
Table 83. Granules India Limited Recent Developments
Table 84. Hebei Jiheng Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 85. Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Models, Specifications and Application
Table 86. Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 87. Hebei Jiheng Pharmaceutical Company Profile and Main Business
Table 88. Hebei Jiheng Pharmaceutical Recent Developments
Table 89. Zhejiang Kangle Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 90. Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Models, Specifications and Application
Table 91. Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 92. Zhejiang Kangle Pharmaceutical Company Profile and Main Business
Table 93. Zhejiang Kangle Pharmaceutical Recent Developments
Table 94. Hunan Zhongnan Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 95. Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Models, Specifications and Application
Table 96. Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 97. Hunan Zhongnan Pharmaceutical Company Profile and Main Business
Table 98. Hunan Zhongnan Pharmaceutical Recent Developments
Table 99. Hebei Jingye Medical Technology Company Information, Head Office, Market Area and Industry Position
Table 100. Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Models, Specifications and Application
Table 101. Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 102. Hebei Jingye Medical Technology Company Profile and Main Business
Table 103. Hebei Jingye Medical Technology Recent Developments
List of Figure
Figure 1. Analgesic and Anti-inflammatory API Picture
Figure 2. By Revenue, Global Analgesic and Anti-inflammatory API Market Size and Forecast, 2019-2030, US$ Million
Figure 3. By Sales Volume, Global Analgesic and Anti-inflammatory API Market Size and Forecast, 2019-2030, (Tons)
Figure 4. Global Analgesic and Anti-inflammatory API Price Trend, 2019-2030, (US$/Ton)
Figure 5. By Revenue, China Analgesic and Anti-inflammatory API Market Size and Forecast, 2019-2030, US$ million
Figure 6. By Sales Volume, China Analgesic and Anti-inflammatory API Market Size and Forecast, 2019-2030, (Tons)
Figure 7. China Analgesic and Anti-inflammatory API Price Trend, 2019-2030 (US$/Ton)
Figure 8. By Revenue, China Analgesic and Anti-inflammatory API Share of Global Market, 2019-2030
Figure 9. By Sales Volume, China Analgesic and Anti-inflammatory API Share of Global Market, 2019-2030
Figure 10. Global Analgesic and Anti-inflammatory API Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Analgesic and Anti-inflammatory API Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Analgesic and Anti-inflammatory API Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Analgesic and Anti-inflammatory API Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Analgesic and Anti-inflammatory API Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024
Figure 15. Chinese Local Players, Proportion of Analgesic and Anti-inflammatory API Domestic VS Export, 2022
Figure 16. Global Analgesic and Anti-inflammatory API Capacity, Production and Capacity Utilization, 2019-2030
Figure 17. Global Analgesic and Anti-inflammatory API Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Analgesic and Anti-inflammatory API Production Market Share & Forecast by Region, 2019-2030
Figure 19. Analgesic and Anti-inflammatory API Industry Chain
Figure 20. Analgesic and Anti-inflammatory API Procurement Model
Figure 21. Analgesic and Anti-inflammatory API Sales Model
Figure 22. Analgesic and Anti-inflammatory API Sales Channels, Direct Sales and Distribution
Figure 23. Ibuprofen
Figure 24. Paracetamol
Figure 25. Aspirin
Figure 26. Naproxen
Figure 27. Diclofenac
Figure 28. Oxaprozin
Figure 29. Dexibuprofen
Figure 30. Others
Figure 31. By Type, Global Analgesic and Anti-inflammatory API Revenue, 2019-2030, US$ Million
Figure 32. By Type, Global Analgesic and Anti-inflammatory API Revenue Market Share, 2019-2030
Figure 33. By Type, Global Analgesic and Anti-inflammatory API Sales Volume, 2019-2030, (Tons)
Figure 34. By Type, Global Analgesic and Anti-inflammatory API Sales Volume Market Share, 2019-2030
Figure 35. By Type, Global Analgesic and Anti-inflammatory API Price, 2019-2030, (US$/Ton)
Figure 36. Adults
Figure 37. Children
Figure 38. By Application, Global Analgesic and Anti-inflammatory API Revenue, 2019-2030, US$ Million
Figure 39. By Application, Global Analgesic and Anti-inflammatory API Revenue Market Share, 2019-2030
Figure 40. By Application, Global Analgesic and Anti-inflammatory API Sales Volume, 2019-2030, (Tons)
Figure 41. By Application, Global Analgesic and Anti-inflammatory API Sales Volume Market Share, 2019-2030
Figure 42. By Application, Global Analgesic and Anti-inflammatory API Price, 2019-2030, (US$/Ton)
Figure 43. By Region, Global Analgesic and Anti-inflammatory API Revenue Market Share, 2019-2030
Figure 44. By Region, Global Analgesic and Anti-inflammatory API Sales Volume Market Share, 2019-2030
Figure 45. North America Analgesic and Anti-inflammatory API Revenue & Forecasts, 2019-2030, US$ Million
Figure 46. By Country, North America Analgesic and Anti-inflammatory API Revenue Market Share, 2022
Figure 47. Europe Analgesic and Anti-inflammatory API Revenue & Forecasts, 2019-2030, US$ Million
Figure 48. By Country, Europe Analgesic and Anti-inflammatory API Revenue Market Share, 2022
Figure 49. Asia Pacific Analgesic and Anti-inflammatory API Revenue & Forecasts, 2019-2030, US$ Million
Figure 50. By Country/Region, Asia Pacific Analgesic and Anti-inflammatory API Revenue Market Share, 2022
Figure 51. South America Analgesic and Anti-inflammatory API Revenue & Forecasts, 2019-2030, US$ Million
Figure 52. By Country, South America Analgesic and Anti-inflammatory API Revenue Market Share, 2022
Figure 53. Middle East & Africa Analgesic and Anti-inflammatory API Revenue & Forecasts, 2019-2030, US$ Million
Figure 54. U.S. Analgesic and Anti-inflammatory API Sales Volume, 2019-2030, (Tons)
Figure 55. By Company, U.S. Analgesic and Anti-inflammatory API Market Share, 2022
Figure 56. By Type, U.S. Analgesic and Anti-inflammatory API Sales Volume Market Share, 2022 VS 2029
Figure 57. By Application, U.S. Analgesic and Anti-inflammatory API Sales Volume Market Share, 2022 VS 2029
Figure 58. Europe Analgesic and Anti-inflammatory API Sales Volume, 2019-2030, (Tons)
Figure 59. By Company, Europe Analgesic and Anti-inflammatory API Market Share, 2022
Figure 60. By Type, Europe Analgesic and Anti-inflammatory API Sales Volume Market Share, 2022 VS 2029
Figure 61. By Application, Europe Analgesic and Anti-inflammatory API Sales Volume Market Share, 2022 VS 2029
Figure 62. China Analgesic and Anti-inflammatory API Sales Volume, 2019-2030, (Tons)
Figure 63. By Company, China Analgesic and Anti-inflammatory API Market Share, 2022
Figure 64. By Type, China Analgesic and Anti-inflammatory API Sales Volume Market Share, 2022 VS 2029
Figure 65. By Application, China Analgesic and Anti-inflammatory API Sales Volume Market Share, 2022 VS 2029
Figure 66. Japan Analgesic and Anti-inflammatory API Sales Volume, 2019-2030, (Tons)
Figure 67. By Company, Japan Analgesic and Anti-inflammatory API Market Share, 2022
Figure 68. By Type, Japan Analgesic and Anti-inflammatory API Sales Volume Market Share, 2022 VS 2029
Figure 69. By Application, Japan Analgesic and Anti-inflammatory API Sales Volume Market Share, 2022 VS 2029
Figure 70. South Korea Analgesic and Anti-inflammatory API Sales Volume, 2019-2030, (Tons)
Figure 71. By Company, South Korea Analgesic and Anti-inflammatory API Market Share, 2022
Figure 72. By Type, South Korea Analgesic and Anti-inflammatory API Sales Volume Market Share, 2022 VS 2029
Figure 73. By Application, South Korea Analgesic and Anti-inflammatory API Sales Volume Market Share, 2022 VS 2029
Figure 74. Southeast Asia Analgesic and Anti-inflammatory API Sales Volume, 2019-2030, (Tons)
Figure 75. By Company, Southeast Asia Analgesic and Anti-inflammatory API Market Share, 2022
Figure 76. By Type, Southeast Asia Analgesic and Anti-inflammatory API Sales Volume Market Share, 2022 VS 2029
Figure 77. By Application, Southeast Asia Analgesic and Anti-inflammatory API Sales Volume Market Share, 2022 VS 2029
Figure 78. India Analgesic and Anti-inflammatory API Sales Volume, 2019-2030, (Tons)
Figure 79. By Company, India Analgesic and Anti-inflammatory API Market Share, 2022
Figure 80. By Type, India Analgesic and Anti-inflammatory API Sales Volume Market Share, 2022 VS 2029
Figure 81. By Application, India Analgesic and Anti-inflammatory API Sales Volume Market Share, 2022 VS 2029
Figure 82. Middle East & Asia Analgesic and Anti-inflammatory API Sales Volume, 2019-2030, (Tons)
Figure 83. By Company, Middle East & Asia Analgesic and Anti-inflammatory API Market Share, 2022
Figure 84. By Type, Middle East & Asia Analgesic and Anti-inflammatory API Sales Volume Market Share, 2022 VS 2029
Figure 85. By Application, Middle East & Asia Analgesic and Anti-inflammatory API Sales Volume Market Share, 2022 VS 2029
Figure 86. Research Methodology
Figure 87. Breakdown of Primary Interviews
Figure 88. Bottom-up Approaches
Figure 89. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|